Helicobacter Pylori Infection in Acute Myocardial Infarction Patients

March 15, 2023 updated by: Asmaa Ezz Mostafa, Sohag University

The Study of Helicobacter Pylori Infection in Acute Myocardial Infarction Patients

This study aims to investigate the association between H.Pylori and ACS .

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The study is based on show the relationship between H.Pylori infection and Acute Coronary Syndrome .

Active H.Pylori infection is common in ACS and may represent a modifiable risk factor for upper gastrointestinal bleeding.

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Lotfy H Abu Dahb, Prof
  • Phone Number: 01003459739

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients presenting by acute coronary syndrome to Coronary Care Units and the chronic stable angina patients.

Description

Inclusion Criteria:

  • All patients presenting by acute coronary syndrome to Coronary Care Units, Internal Medicine Department, Sohag Faculty of Medicine from 18 .

Exclusion Criteria:

  • 1.Patients with Cardiogenic Shock. 2. Renal Impairment.(Creatinine Clearence <60) 3. A known systemic inflammatory condition. 4.They had taken any antibiotics in the previous 1 months. 5.They had taken any proton pump inhibitors in previous 2 weeks. 6.Gastrointestinal Bleeding.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Acute Coronary Syndrome Patients
Stool Analysis will be done for all cases to detect H.pylori Antigen and results will be analysed into infected patients and non infected patients.
Diagnostic test: Stool Analysis
Stool Analysis to detect H.Pylori Antigen in Stool
Chronic Stable Angina Patients
Stool Analysis will be done for all cases to detect H.pylori Antigen and results will be analysed into infected patients and non infected patients.
Diagnostic test: Stool Analysis
Stool Analysis to detect H.Pylori Antigen in Stool

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of results of H.Pylori antigen with ACS
Time Frame: from the day of admission to the day of disharge of sohag university hospitals
Analysis of H.Pylori antigen and compare with ECG findings and cardiac enzymes
from the day of admission to the day of disharge of sohag university hospitals

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2023

Primary Completion (Anticipated)

October 1, 2023

Study Completion (Anticipated)

January 1, 2024

Study Registration Dates

First Submitted

March 5, 2023

First Submitted That Met QC Criteria

March 15, 2023

First Posted (Actual)

March 28, 2023

Study Record Updates

Last Update Posted (Actual)

March 28, 2023

Last Update Submitted That Met QC Criteria

March 15, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • H.Pylori and AMI

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Coronary Syndrome

Clinical Trials on Stool Analysis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe